Drug Interaction in Infectious Diseases

Drug interactions in infectious diseases are a major source of medical harm that can be avoided. Patients are exposed to a high risk of drug interactions. Drug interactions provide a significant issue for patients and their care providers, according to the approved drug product labels for anti-infective medications, direct-acting antivirals for HCV, and HIV medications. Interactions could also be caused by non-CYP enzymes, CYP enzymes, and variations in stomachic pH, as well as the ever-growing list of drug transporters. Interactions caused by dietary components, flavouring drugs, and biological products are among the other problems.

 

  • Fluoxetine and Phenelzine
  • Digoxin and Quinidine
  • Warfarin and Diflunisal
  • Theophylline and Ciprofloxacin

Related Conference of Drug Interaction in Infectious Diseases

November 21-22, 2024

7th Pathology and Infectious Disease Conference

Dubai, UAE
November 28-29, 2024

20th World Congress on Infection Prevention and Control

Paris, France
March 13-14, 2025

9th International Conference on Rare Diseases

Prague, Czech Republic
March 17-18, 2025

12th International Congress on Infectious Diseases

Berlin, Germany
April 14-15, 2025

15th European Epidemiology and Public Health Congress

Budapest, Hungary
June 02-03, 2025

17th Euro-Global Conference on Infectious Diseases

Amsterdam, Netherlands
June 02-03, 2025

14th World Congress on Rare Diseases and Orphan Drugs

Amsterdam, Netherlands

Drug Interaction in Infectious Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in